Center for Scientific Review Amended; Notice of Meeting, 15133-15134 [2014-05871]
Download as PDF
<![CDATA[
15133
Federal Register / Vol. 79, No. 52 / Tuesday, March 18, 2014 / Notices
of public comment at approximately 5:15
p.m.
Wednesday morning at 8:30 a.m., the
Committee will meet to summarize key
findings and develop a work plan for the next
quarter and the following meeting.
FOR FURTHER INFORMATION CONTACT:
Steve Hirsch, MSLS, Executive
Secretary, National Advisory Committee
on Rural Health and Human Services,
Health Resources and Services
Administration, Parklawn Building,
Room 5A–05, 5600 Fishers Lane,
Rockville, MD 20857, telephone (301)
443–7322, fax (301) 443–2803.
Persons interested in attending any
portion of the meeting should contact
Kristen Lee at the Office of Rural Health
Policy (ORHP) via telephone at (301)
443–6884 or by email at klee1@hrsa.gov.
The Committee meeting agenda will be
posted on ORHP’s Web site https://
www.hrsa.gov/advisorycommittees/
rural/.
Dated: March 12, 2014.
Jackie Painter,
Deputy Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–05950 Filed 3–17–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery (NCI)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
National Cancer Institute, 9609 Medical
Center Drive, Bethesda, MD 20892–9760
or call non-toll-free number 240–276–
6850 or Email your request
horovitchkellv@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
DATES: Comments Due: Comments
regarding this information collection are
best assured of having their full effect if
received by May 19, 2014.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Vivian Horovitch-Kelley, Office
of Management Policy and Compliance,
SUMMARY:
SUPPLEMENTARY INFORMATION:
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (NCI), 0925–0642, Expiration
Date 9/31/2014, EXTENSION, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: There are no changes being
requested for this submission. The
information collection activity is
garnering qualitative customer and
stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. This generic
provides information about the National
Cancer Institute’s customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. It also allows
feedback to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance provides useful information
but it will not yield data that can be
generalized to the overall population.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated burden hours are 8,750.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of collection
emcdonald on DSK67QTVN1PROD with NOTICES
Surveys ............................................................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Focus Groups ..................................................................................................
Website or Software Usability Tests ................................................................
1000
500
2000
3000
Dated: March 11, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–05962 Filed 3–17–14; 8:45 am]
Center for Scientific Review Amended;
Notice of Meeting
BILLING CODE 4140–01–P
National Institutes of Health
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, March
VerDate Mar<15>2010
18:34 Mar 17, 2014
Jkt 232001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
1
1
Average
burden per
response
(in hours)
30/60
90/60
90/60
90/60
Total burden
hours
500
750
3,000
4,500
03, 2014, 02:00 p.m. to March 03, 2014,
05:00 p.m., National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD,
20892 which was published in the
Federal Register on February 25, 2014,
78 FR 10541 pg. 10541–10542.
The meeting will be held at the
National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
The meeting will start on April 1, 2014
E:\FR\FM\18MRN1.SGM
18MRN1
15134
Federal Register / Vol. 79, No. 52 / Tuesday, March 18, 2014 / Notices
at 11:00 a.m. and end on April 1, 2014
at 1:00 p.m. The meeting location
remains the same. The meeting is closed
to the public.
Dated: March 11, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05871 Filed 3–17–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
emcdonald on DSK67QTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Aging, Cardiovascular Disorders
and Capacity Building.
Date: April 3, 2014.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Glioblastoma, Dementia and
Multiple Sclerosis.
Date: April 4, 2014.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
VerDate Mar<15>2010
19:45 Mar 17, 2014
Jkt 232001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
SIDS and BRAIN.
Date: April 7, 2014.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: A Predictive Understanding of Cell
Motility.
Date: April 8–9, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Paul Sammak, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
MSC 7892, Bethesda, MD 20892, 301–435–
0601, sammakpj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 13–008
Shared Instrumentation: Bioengineering
Sciences.
Date: April 10, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ping Fan, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5154,
MSC 7840, Bethesda, MD 20892, 301–408–
9971, fanp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Molecular
Neuroscience.
Date: April 14, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4811,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Dated: March 11, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05872 Filed 3–17–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Basic Research in the Pathogenesis of HIVRelated Heart, Lung and Blood Diseases
(R01).
Date: April 16, 2014.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Tony L Creazzo, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Basic Research in the Pathogenesis of HIVRelated Heart, Lung and Blood Diseases
(R21).
Date: April 16, 2014.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Tony L Creazzo, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute, Special Emphasis Panel;
Clinical Research in Prevention, Diagnosis,
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 79, Number 52 (Tuesday, March 18, 2014)]
[Notices]
[Pages 15133-15134]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05871]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the Center for
Scientific Review Special Emphasis Panel, March 03, 2014, 02:00 p.m. to
March 03, 2014, 05:00 p.m., National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal
Register on February 25, 2014, 78 FR 10541 pg. 10541-10542.
The meeting will be held at the National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892. The meeting will start on April 1,
2014
[[Page 15134]]
at 11:00 a.m. and end on April 1, 2014 at 1:00 p.m. The meeting
location remains the same. The meeting is closed to the public.
Dated: March 11, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-05871 Filed 3-17-14; 8:45 am]
BILLING CODE 4140-01-P
